- Home
- EXFY vs CYBN Comparison
EXFY vs CYBN Comparison
Compare EXFY & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXFY
- CYBN
- Stock Information
- Founded
- EXFY 2008
- CYBN 2019
- Country
- EXFY United States
- CYBN Canada
- Employees
- EXFY N/A
- CYBN N/A
- Industry
- EXFY Computer Software: Prepackaged Software
- CYBN Pharmaceuticals and Biotechnology
- Sector
- EXFY Technology
- CYBN Health Care
- Exchange
- EXFY Nasdaq
- CYBN Nasdaq
- Market Cap
- EXFY 241.7M
- CYBN 229.8M
- IPO Year
- EXFY 2021
- CYBN N/A
- Fundamental
- Price
- EXFY $3.32
- CYBN $10.19
- Analyst Decision
- EXFY Buy
- CYBN Strong Buy
- Analyst Count
- EXFY 4
- CYBN 3
- Target Price
- EXFY $2.83
- CYBN $138.00
- AVG Volume (30 Days)
- EXFY 786.0K
- CYBN 559.2K
- Earning Date
- EXFY 11-07-2024
- CYBN 11-13-2024
- Dividend Yield
- EXFY N/A
- CYBN N/A
- EPS Growth
- EXFY N/A
- CYBN N/A
- EPS
- EXFY N/A
- CYBN N/A
- Revenue
- EXFY $137,440,000.00
- CYBN N/A
- Revenue This Year
- EXFY N/A
- CYBN N/A
- Revenue Next Year
- EXFY $7.39
- CYBN N/A
- P/E Ratio
- EXFY N/A
- CYBN N/A
- Revenue Growth
- EXFY N/A
- CYBN N/A
- 52 Week Low
- EXFY $1.24
- CYBN $6.50
- 52 Week High
- EXFY $3.34
- CYBN $21.66
- Technical
- Relative Strength Index (RSI)
- EXFY 80.91
- CYBN 47.03
- Support Level
- EXFY $2.63
- CYBN $10.36
- Resistance Level
- EXFY $2.97
- CYBN $13.88
- Average True Range (ATR)
- EXFY 0.22
- CYBN 1.32
- MACD
- EXFY 0.10
- CYBN -0.08
- Stochastic Oscillator
- EXFY 99.01
- CYBN 8.40
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.